Lv4
480 积分 2024-09-17 加入
PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy
2天前
已完结
Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway
2天前
已完结
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML
3天前
已关闭
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
3天前
已完结
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML
3天前
已关闭
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells
3天前
已关闭
Cellular functions of cGAS-STING signaling
11天前
已完结
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
16天前
已完结
Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
16天前
已完结
SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells
16天前
已完结
皖公网安备34019202002308
